logo
episode-header-image
Jan 2024
2m 41s

Podcast 888: Low GCS and Intubation

EMERGENCY MEDICAL MINUTE
About this episode

Contributor: Aaron Lessen MD

Educational Pearls:

Is the adage, “GCS of 8, you’ve got to intubate” accurate? A recent study published in the November 2023 issue of JAMA attempted to answer this question.

Design

  • Multicenter, randomized trial, in France from 2021 to 2023.

  • 225 patients experiencing comatose in the setting of acute poisoning were randomly assigned to either a conservative airway strategy of withholding intubation or “routine practice” of much more frequent intubation.

  • The primary outcome was a composite endpoint including in-hospital death, length of intensive care unit stay, and length of hospital stay.

  • Secondary outcomes included adverse events from intubation and pneumonia within 48 hours.

Results

  • Results showed that in the intervention group (with intubation withholding), only 16% of patients were intubated, compared to 58% in the control group.

  • No in-hospital deaths occurred in either group.

  • The intervention group demonstrated a significant clinical benefit for the primary endpoint, with a win ratio of 1.85 (95% CI, 1.33 to 2.58).

  • The conservative airway management strategy also saw a statistically significant decrease in adverse events from intubation and pneumonia.

Conclusion

  • Among comatose patients with suspected acute poisoning, a conservative strategy of withholding intubation was associated with a greater clinical benefit.

  • This suggests that a judicious approach to intubation is appropriate in many other settings and clinicians should rely on more than the GCS to make this decision.

References

  1. Freund Y, Viglino D, Cachanado M, Cassard C, Montassier E, Douay B, Guenezan J, Le Borgne P, Yordanov Y, Severin A, Roussel M, Daniel M, Marteau A, Peschanski N, Teissandier D, Macrez R, Morere J, Chouihed T, Roux D, Adnet F, Bloom B, Chauvin A, Simon T. Effect of Noninvasive Airway Management of Comatose Patients With Acute Poisoning: A Randomized Clinical Trial. JAMA. 2023 Dec 19;330(23):2267-2274. doi: 10.1001/jama.2023.24391. PMID: 38019968; PMCID: PMC10687712.

Summarized by Jeffrey Olson MS2 | Edited by Meg Joyce & Jorge Chalit, OMSII

 

Up next
Mar 2025
Episode 946: Time to Defibrillation
Contributor: Aaron Lessen, MD Educational Pearls: Quick background info Cardiac arrest is when the heart stops pumping blood for any reason. This is different from a heart attack in which the heart is still working but the muscle itself is starting to die. One cause of cardiac ar ... Show More
2m 30s
Feb 2025
Episode 945: Ketorolac vs. Ibuprofen
Contributor: Ricky Dhaliwal, MD Educational Pearls:  Ketorolac and ibuprofen are NSAIDs with equivalent efficacy for pain in the emergency department Oral ibuprofen provides the same relief as intramuscular ketorolac IM ketorolac is associated with the adverse effect of a painful ... Show More
3m 30s
Feb 2025
Episode 944: Colchicine Overdose
Contributor: Aaron Lessen, MD Educational Pearls: Colchicine is most commonly used for the prevention and treatment of gout There is research investigating the anti-inflammatory and cardioprotective effects of colchicine  This drug has a narrow therapeutic index: a small margin b ... Show More
3m 19s
Recommended Episodes
Dec 2020
20: Do lower intraoperative tidal volumes reduce postoperative pulmonary complications?
In this episode, we explore the evidence on whether lower intraoperative tidal volumes (e.g., 6 vs. 9 cc/kg) reduce postoperative pulmonary complications. Our guest is Dr. Avery Tung. Dr. Tung is Professor of Anesthesia & Critical Care at the University of Chicago and Section Edi ... Show More
39m 14s
Oct 2023
November 2023 Neurology Recall: Topics in Stroke
The November 2023 replay of past episodes showcases five interviews on topics in stroke. The episode begins with an interview with Dr. Imogene Scott on prehospital telestroke vs paramedic scores to accurately identify stroke reperfusion candidates. The episode continues with an i ... Show More
1h 35m
Feb 2024
Key Advances in Prostate, Kidney, and Bladder Cancers at GU24
Drs. Neeraj Agarwal and Todd Morgan discuss CONTACT-02, KEYNOTE-564, CheckMate-67T, and other notable studies featured at the 2024 ASCO Genitourinary Cancers Symposium, as well as additional key abstracts in prostate, kidney, and bladder cancers that will significantly influence ... Show More
30m 6s
May 2024
Key Abstracts in GU Cancers at ASCO24
Dr. Neeraj Agarwal and Dr. Jeanny Aragon-Ching discuss promising combination therapies and other compelling advances in genitourinary cancers in advance of the 2024 ASCO Annual Meeting. TRANSCRIPT Dr. Neeraj Agarwal: Hello and welcome to the ASCO Daily News Podcast. I'm Dr. Neera ... Show More
26m 4s
Dec 2023
36. Does tranexamic acid increase the risk of thromboembolism?
Dr. Zach Cost and Dr. Tem Bendapudi join the show to discuss the literature pertaining to tranexamic acid and thromboembolic risk. Dr. Zach Cost is an anesthesia resident at the Massachusetts General Hospital. Dr. Pavan (“Tem”) Bendapudi holds a joint faculty appointment in the D ... Show More
1 h
Jan 2024
What’s New in Prostate Cancer, RCC, and mUC at GU24
Drs. Neeraj Agarwal and Jeanny Aragon-Ching discuss several key abstracts to be presented at the 2024 ASCO GU Cancers Symposium, including sequencing versus upfront combination therapies for mCRPC in the BRCAAway study, updates on the CheckMate-9ER and CheckMate-214 trials in ccR ... Show More
25m 10s
Mar 2024
363. GLP-1 Agonists: Diving into the Data with Dr. Darren McGuire
Welcome back to the CardioNerds Cardiovascular Prevention Series, where we are continuing our discussion of Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs). This class of medications is becoming a household name, not only for their implications for weight loss but also for ... Show More
43m 1s
May 2024
Day 1: Top Takeaways From ASCO24
In the first episode of a special daily series during the 2024 ASCO Annual Meeting, Dr. John Sweetenham shares highlights from Day 1, including exciting data on the CROWN trial in NSCLC, the ASC4First study in chronic myeloid leukemia, and the effects of high-deductible health pl ... Show More
10m 35s
Apr 2024
Social Deprivation in Vascular Surgery
In this episode Abena Appah-Sampong (@abenasamp) and Leana Dogbe (@leanadogbe) partner with Vaiva Dabravolskaite (vaivadabravolskaite@gmail.com) from ESVS to host an episode discussing social deprivation in vascular surgery. Dr. Tara Mastracci and Dr. Olamide Alabi join us to off ... Show More
1h 6m
Feb 2024
New 2024 Guidelines: Corticosteroids in Sepsis, ARDS, and CAP
This episode delves into the 2024 update on corticosteroid guidelines for critically ill patients with sepsis, ARDS, and community-acquired pneumonia. We break down the recommendations, evidence, and clinical implications of this crucial guidance for healthcare providers. The Vas ... Show More
6m 51s